Lv41
730 积分 2023-12-14 加入
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
3小时前
待确认
Targeted degradation of membrane and extracellular proteins with LYTACs
12天前
已完结
Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice
1个月前
已完结
Bacteria-mediated tumor-targeted delivery of tumstatin (54-132) significantly suppresses tumor growth in mouse model by inhibiting angiogenesis and promoting apoptosis
2个月前
已完结
Subvisible Particle Analysis of 17 Monoclonal Antibodies Approved in China Using Flow Imaging and Light Obscuration
2个月前
已完结
A review of antibody-based therapeutics targeting G protein-coupled receptors: an update
9个月前
已完结
GPCR drug discovery: new agents, targets and indications
9个月前
已完结
A comprehensive review of GPR84: A novel player in pathophysiology and treatment
9个月前
已完结
E3 ligase ligand chemistries: from building blocks to protein degraders
9个月前
已完结
Nucleic acid-based drugs for patients with solid tumours
9个月前
已完结
皖公网安备34019202002308
